Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Aardvark Therapeutics, Inc. (AARD) had Weighted-Average Shares Outstanding (Diluted) of 19.62M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-17.60M |
|
-- |
|
-- |
|
$18.70M |
|
$-18.70M |
|
$1.11M |
|
$-17.60M |
|
$-17.58M |
|
$-17.60M |
|
$-17.60M |
|
$-17.60M |
|
$-17.58M |
|
$-18.70M |
|
$-18.93M |
|
19.62M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
19.62M |
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$111.89M |
|
-- |
|
$5.29M |
|
$117.18M |
|
$10.55M |
|
-- |
|
-- |
|
$10.55M |
|
$106.63M |
|
$106.63M |
|
$106.63M |
|
21.82M |
|
| Cash Flow Statement Financials | |
$-54.17M |
|
$-49.67M |
|
$89.25M |
|
$61.64M |
|
$47.05M |
|
$-14.59M |
|
$3.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-54.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.50% |
|
-16.50% |
|
-15.02% |
|
-16.50% |
|
$4.89 |
|
$-2.77 |
|
$-2.76 |
|